CiVi Biopharma ApS: Financial statements 2018
CVR: 38027794
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CiVi Biopharma ApS (CVR 38027794) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 6,038,811 and a net result of DKK 706,732. Equity in the 2018 report amounted to DKK 1,664,330. The solvency ratio was 23.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 6,038,811
- Profit/Loss
- DKK 706,732
- Equity
- DKK 1,664,330
- Total Assets
- DKK 7,037,220
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CiVi Biopharma ApS has published its interim report for the period September 20, 2016 to December 31, 2017.
About CiVi Biopharma ApS
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 5 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.